ZURICH, Switzerland, January 9 /PRNewswire/ --

ESBATech AG, a leading developer of antibody fragment therapeutics, today announced the initiation of the Phase I/IIa clinical development of its anti-TNF alpha antibody fragment ESBA105 in osteoarthritis (OA). This double-blind, randomized, placebo-controlled Phase I/IIa clinical study is designed to investigate the safety, tolerability and efficacy on pain with ESBA105 applied locally via intra-articular administration to patients with severely painful OA of the knee. The multicenter study is initiated at various sites across Switzerland.

SAN DIEGO, January 9 /PRNewswire/ --

Victory Pharma, Inc., a privately held specialty pharmaceutical company, today announced that it is launching two additional dosage strengths of NAPRELAN(R) (naproxen sodium) Controlled-Release Tablets. NAPRELAN is a once-daily, controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of a number of conditions, including osteoarthritis, rheumatoid arthritis and management of mild to moderate pain. VICTORY'S promotional efforts will be directed primarily at pain management specialists, rheumatologists, orthopedic surgeons and selected primary care physicians.

LONDON, January 9 /PRNewswire/ --

- New Online Service Provides the Best Chance of Excelling in Examinations and Tests at Whatever Age

A new website has been launched by the Be Free From Partnership. It is designed specifically to get rid of all examination, test and interview nerves. The service is EXAM AID and it can be found at http://www.befreefrom.com. The website gives detailed personalized instruction, there and then, on how to get rid of exam and test nerves. At the end it provides a free optional print out of the personalised instructions for later use. It costs GBP10 and if the instructions do not work, the company offer a 'no quibble' money back guarantee.

6 newly discovered genes for obesity have a neural effect, according to the international GIANT (Genetic Investigation of Anthropometric Parameters) consortium.

So far, the scientists have analyzed two million DNA variations in 15 genome-wide association studies with a total of more than 32,000 participants and the identified candidate genes were validated in 14 further studies including 59,000 participants.

In addition to the FTO and MC4R genes already known, it was now possible for six more obesity genes to be identified: TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2, and NEGR1.

The International Year of Astronomy 2009 (IYA2009) is a global celebration of astronomy and its contribution to society and culture, with strong emphasis on education, public participation, and the involvement of young people, and with events at national, regional, and global levels. Many thousands of individuals in over 135 countries around the world are already involved, forming the world's largest ever astronomy network.

IYA2009 portrays astronomy as a peaceful global scientific endeavour that unites astronomers in an international, multicultural family of scientists, working together to find answers to some of the most fundamental questions that humankind has ever asked.

When Charles Darwin published his landmark book On the Origin of Species(*) in 1859, his theories on evolution were quickly accepted by the vast majority of scientists. The general public, however, was not as eager to accept Darwin’s ideas, due largely to the fact that they challenged established religious beliefs.

Today, 150 years after the publication of Darwin’s book, science and religion remain as conflicted as ever when it comes to the subject of evolution.

“There is a real disconnect between what science says and what the public believes, at least in the United States,” says Ben Pierce, holder of the Lillian Nelson Pratt Chair in Biology at Southwestern University in Georgetown, Texas. 

SAN FRANCISCO, January 9 /PRNewswire/ --

- Kenshoo Announces an iPhone Interface for KENSHOO SEARCH

Kenshoo Inc. is excited to announce that KENSHOO SEARCH, the next generation Search Engine Marketing campaign management solution, is now accessible from iPhone. Kenshoo clients who are also iPhone users will now be able to view campaign statistics and reports on their iPhone browser.